Clinical Trial Update: Fluorouracil, Cisplatin, Cetuximab, and Radiation Therapy in Treating Patients With Esophageal Cancer That Can Be Removed by Surgery [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluating a multimodal regimen of fluorouracil, cisplatin, cetuximab, and radiation therapy for resectable esophageal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Cetuximab (cetuximab)
• FLUOROURACIL (Fluorouracil)

Snippet

Sponsor: Federation Francophone de Cancerologie Digestive | Conditions: Esophageal Cancer | Phase 1, Phase 2 | Status: COMPLETED